Diabetes and silent atrial fibrillation: A dangerous liaison?

Area of Science:

• Cardiology
• Neurology
• Endocrinology

Background:

• Diabetic patients exhibit a higher risk of stroke compared to non-diabetic individuals.
• A significant portion of strokes in diabetics (25%) have an undetermined etiology.
• Subclinical atrial fibrillation (AF) is hypothesized as a potential cause for these strokes.

Purpose of the Study:

• To investigate the association between subclinical atrial fibrillation (AF) and stroke risk in type-2 diabetic patients.
• To determine if silent cerebral infarcts are more prevalent in diabetic patients with undiagnosed AF.
• To assess the impact of silent AF on the incidence of stroke during follow-up.

Main Methods:

• A cohort study comparing 464 type-2 diabetic patients with 240 healthy controls.
• Patients were monitored for a 37-month follow-up period.
• Prevalence of silent cerebral infarcts at baseline was compared between diabetic patients with and without silent AF.

Main Results:

• Silent cerebral infarcts were significantly more common in diabetic patients with silent AF (61%) compared to those without silent AF (29%; p < 0.001).
• The presence of silent AF at baseline was associated with a higher number of stroke events during the follow-up period.
• Diabetic patients with silent AF demonstrated a higher burden of cerebrovascular damage.

Conclusions:

• Subclinical atrial fibrillation is a prevalent finding in type-2 diabetic patients and a significant risk factor for stroke.
• Screening for silent AF in diabetic populations may help identify individuals at high risk for stroke.
• Addressing silent AF could be a crucial strategy in reducing stroke incidence among diabetic patients.